Chennai Meenakshi Multispeciality has postponed its board meeting from August 28 to September 1, 2026, citing unavoidable administrative reasons. The directors will consider the annual results for FY26 and approve the agenda for the upcoming general meeting.

The company issued the intimation on August 27, 2026, pursuant to Regulation 29 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda Items

The board will address several key corporate governance matters during the rescheduled session:

• Fixing the date, time, and mode for the 36th Annual General Meeting (AGM).
• Approving the Board's Report and the Notice of the AGM for the fiscal year ended March 31, 2026.
• Determining book closure dates and the record date for e-voting.
• Appointing a scrutinizer for the e-voting process.
• Considering any other business with the permission of the Chair.

Corporate Details

The company, formerly known as Devaki Hospital Limited, operates from Luz Church Road in Chennai. It holds ISO 9001:2008 and ISO 14001:2004 certifications. M.S. Ananthalakshmi, the Company Secretary and Compliance Officer, issued the updated notice on August 27, 2026.

Chennai Meenakshi Multispeciality Hospital Limited reported a net profit of ₹0.28 lakh for the quarter ended June 30, 2026, reversing a net loss of ₹74.11 lakh recorded in the corresponding period of FY26. The turnaround was driven by a reduction in operating losses, with total income at ₹870.46 lakh against total expenses of ₹871.98 lakh. This marks a significant improvement from Q1FY26, where the company incurred a pre-tax loss of ₹75.59 lakh. The Board of Directors approved the unaudited financial results on August 11, 2026, alongside key leadership appointments aimed at strengthening operational and governance structures.

The filing was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial results were prepared in accordance with Indian Accounting Standard (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. Elias George & Co., the statutory auditors, conducted a limited review of the interim financial information pursuant to Regulation 33 of the SEBI LODR Regulations, 2015, and issued a clean review report.

Financial Performance

Revenue from operations declined marginally to ₹859.02 lakh in Q1FY27 from ₹864.90 lakh in Q1FY26. Other income also decreased to ₹11.44 lakh from ₹26.98 lakh in the prior year quarter. Total income for the period was ₹870.46 lakh, compared to ₹891.88 lakh in Q1FY26.

Total expenses were contained at ₹871.98 lakh, down significantly from ₹967.47 lakh in Q1FY26. This reduction was primarily due to lower employee benefit expenses (₹187.89 lakh vs ₹241.61 lakh) and other expenses (₹478.16 lakh vs ₹505.14 lakh). Purchase of stock-in-trade remained stable at ₹159.83 lakh. Finance costs were ₹22.17 lakh, nearly unchanged from ₹22.22 lakh in the previous year.

Leadership Appointments

The Board appointed Dr Thanigai Vendan Moorrthy as Chief Executive Officer (in Non-Director Capacity) and Key Managerial Personnel for a term of five years, effective August 11, 2026. Dr Moorrthy is a Senior Anesthesiologist with over 15 years of clinical expertise and healthcare executive experience.

Additionally, the Board appointed three new Additional Directors in the capacity of Non-Executive Independent Directors, subject to shareholder approval at the ensuing Annual General Meeting:

• A F Simeon Telfer (DIN: 11879121), an entrepreneur with experience in business development and corporate governance.
• R V Ramanuja Bharathi (DIN: 08553270), an advocate specializing in legal strategy and corporate law.
• Sindu Chawla (DIN: 11879201), a software engineering leader with over 15 years of experience in network architecture.

Committee Reconstitution

Consequent to these appointments, the Board reconstituted its Audit Committee and Stakeholders Relationship Committee effective August 11, 2026.

Audit Committee:

• Chairman: M. Karunakaran (Independent Non-Executive Director)
• Members: A F Simeon Telfer (Independent Non-Executive Director), Jayanthi Radhakrishnan (Executive Director)

Stakeholders Relationship Committee:

• Chairman: Sindu Chawla (Independent Non-Executive Director)
• Members: R V Ramanuja Bharathi (Independent Non-Executive Director), Edward Prabhakar (Non-Executive Director)

What the Numbers Show

The shift from a significant loss to a marginal profit indicates improved cost containment rather than revenue growth. While revenue dipped slightly, the substantial reduction in total expenses—particularly in employee benefits and other operational costs—allowed the company to narrow its deficit to near break-even levels. The deferred tax credit of ₹1.80 lakh contributed to the final profit figure, offsetting the pre-tax loss of ₹1.52 lakh.